As of June 30, 2026, Lunai Bioworks Inc. operated principally through two operating subsidiaries, Renovaro Biosciences and BioSymetrics; a third wholly owned subsidiary, Lunai Bioworks IP, Inc., holds the intellectual property acquired in the May 2026 Neurobridge acquisition, including the N2B intranasal drug delivery platform. BioSymetrics refers to BioSymetrics Inc. and its wholl…
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$52K
Net Income (TTM)
-$4M
▲ +98.0% YoY
Op. Margin
-16729.37%
ROIC
-1031.25%
▼ -809.3pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$5M
▲ +32.8% YoY
Op. Cash Flow (TTM)
-$5M
▲ +32.8% YoY
Net Debt
-$1M
Net Cash Position
Cash & Equiv.
$2M
Continue Research
Peers
Pharmaceutical Preparations · Pick stocks to compare with LNAI
Lunai Bioworks (LNAI) in four numbers
Questions about Lunai Bioworks
Is Lunai Bioworks (LNAI) overvalued?
At $0.16, Lunai Bioworks' price is 34% above the $0.12 a share fair value that Intrinsiqq's calculator gets from its revenue. The growth behind that figure is yours to set on the Intrinsic Value tab. See how to tell if a stock is overvalued.
What is Lunai Bioworks' fair value?
Intrinsiqq's calculator puts Lunai Bioworks' fair value at $0.12 a share. It grows revenue per share 5% a year for 5 years, applies an exit P/S of 15, and works back at a 10% yearly return. A 25% margin of safety gives a buy-below price of $0.09. Every input can be changed on the Intrinsic Value tab.
Is Lunai Bioworks a high-quality business?
Lunai Bioworks scores 10 out of 100 on Intrinsiqq's quality score, which makes it a lower-quality business on these measures. The score blends 4 checks computed from SEC filings. Its best check is net debt at -$1M, and its weakest is return on capital at -1031.2%. The Quality tab shows every check against its target.
Does Lunai Bioworks (LNAI) pay a dividend?
No. Lunai Bioworks (LNAI) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.
Source: 10-Q filed 13 Oct 2026 (period ending 30 Jun 2026), SEC. Price: last close 29 Oct 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.
Spot a number that looks wrong? Check it in LNAI's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing LNAI
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.